It is a pharma private limited company based in Thrissur, Kerala, India, established in 2005.
2005 | Thrissur, Kerala, India | ActiveFling Pharmaceuticals Private Limited, a active private limited company, was established on 18 November 2005 in Thrissur, Kerala, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232KL2005PTC018835. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.98 M.
It upholds a compliant status. Employing 40 professional, Its leadership includes Madhu Karuvanchery Vijayan Nair (Managing Director), Biju Kapplingattu Krishnan Namboodiri (Whole-Time Director), David Joseph Palayoor (Whole-Time Director). Past directors included Madhu Karuvanchery Vijayan Nair, Bhagya Lakshmi Ravindranathan, Biju Kapplingattu Krishnan Namboodiri. It holds ₹4.45 Cr open charges and ₹1.38 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No. B1, 31/441/5, First Floor, Navamy Regency Sitaram Mill Road, Punkunnam P.O., Thrissur, Kerala, 680002.
U24232KL2005PTC018835
018835
18 November 2005
₹1.00 Cr
₹9.98 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Fling Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhu Karuvanchery Vijayan Nair | Managing Director | 01 Apr 2024 | Current |
| Biju Kapplingattu Krishnan Namboodiri | Whole-Time Director | 11 Mar 2009 | Current |
| David Joseph Palayoor | Whole-Time Director | 12 May 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 May 2023 | Past |
| Pramod Abcsdd | Director | 05 Mar 2019 | Past |
| Pramod Abcsdd | Director | 03 Apr 2009 | Past |
| Pramod Abcsdd | Director | 11 Mar 2009 | Past |
| Pramod Abcsdd | Managing Director | 01 Apr 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Fling Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.19% increase. The company also saw a substantial improvement in profitability, with a 71.65% increase in profit. The company's net worth Soared by an impressive increase of 46.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Fling Pharmaceuticals had a promoter holding of 23.34% and a public holding of 76.66%. The company had 2 Subsidiaries and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹44,543,080.00
₹13,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jan 2025 | Dhanlaxmi Bank Limited | ₹3.40 M | Open |
| 19 Aug 2024 | Others | ₹1.05 Cr | Open |
| 03 Aug 2020 | Dhanlaxmi Bank Limited | ₹2.73 M | Open |
| 06 Oct 2018 | Dhanlaxmi Bank Limited | ₹3.25 M | Open |
| 17 Apr 2018 | Dhanlaxmi Bank Limited | ₹9.66 M | Open |
Explore comprehensive loan charge details -
Fling Pharmaceuticals has a workforce of 40 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Fling Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fling Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Dhanlaxmi Bank Limited of Rs. 0.97 Cr registered on 17 Apr 2018 with Charge ID 100176290 was modified on 19 Feb 2025. was completed.
A charge registered on 22 Mar 2017 via Charge ID 100092649 with Dhanlaxmi Bank Limited was fully satisfied on 19 Feb 2025. was recorded as a recent event.
The activity A charge registered on 21 Jun 2016 via Charge ID 100039504 with Dhanlaxmi Bank Limited was fully satisfied on 19 Feb 2025. was completed.
Progress on A charge with Dhanlaxmi Bank Limited amounted to Rs. 0.34 Cr with Charge ID 101040710 was registered on 08 Jan 2025. was documented.
The activity A charge registered on 19 Mar 2013 via Charge ID 10510561 with Dhanlaxmi Bank Limited was fully satisfied on 05 Nov 2024. was completed.
Progress on Fling Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The CIN of Fling Pharmaceuticals Private Limited is U24232KL2005PTC018835.
Fling Pharmaceuticals Private Limited is headquartered at No. B1, 31/441/5, First Floor, Navamy Regency Sitaram Mill Road, Punkunnam P.O., Thrissur, Kerala, 680002.
Fling Pharmaceuticals Private Limited was incorporated on 18 November 2005.
The current directors of Fling Pharmaceuticals Private Limited are
The primary industry of Fling Pharmaceuticals Private Limited is Manufacturing.
Fling Pharmaceuticals Private Limited is unlisted.
The authorized capital of Fling Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹9.98 M.
The compliance status of Fling Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX